Reviva Pharmaceuticals' Convertible Note - IV Round

Reviva Pharmaceuticals raised a round of funding on May 22, 2017.

Reviva Pharmaceuticals is a pharmaceutical company focused on developing a portfolio of internally discovered next generation safe and effective therapeutic drugs by using an integrated chemical genom…

Articles about Reviva Pharmaceuticals' Convertible Note - IV Round: